CISD1 and cancer: Indeed, CISD1 has emerged as the mitochondrial target of thiazolidinedione drugs such as the antidiabetic pioglitazone [47, 48], suggesting the potential therapeutic value of SB-T-101141 for CISD1-positive cancers.